Business

NewsWatch: Moderna and SpaceX highlighted by a fast-growing U.S. fund traded in London

Baillie Gifford U.S. Growth Trust devoted much of its half-yearly report to talking up the prospects of biotech Moderna and rocket launcher SpaceX, two of its investments that helped lift its net asset value surge during the time frame.

topstories?d=yIl2AUoC8zAnow-trending topstories?i=sPa6CRmrHNk:cpzPIWUv6sM:F7zBnMyn0Lonow-trending topstories?i=sPa6CRmrHNk:cpzPIWUv6sM:V sGLiPBpWUnow-trending topstories?d=qj6IDK7rITsnow-trending

sPa6CRmrHNknow-trending

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button